New hope for those with multiple sclerosis

May 01, 2011

Hear from Stanley Cohan, M.D., Ph.D., medical director of Providence Multiple Sclerosis Center, about how a new FDA approved drug for those with relapsing MS is changing lives and reducing attacks from about 30 percent to almost 70 percent. Research continues and there is hope that there may someday be new therapies to actually repair nervous system damage. Watch this KPTV report.